Evidence map›Paper›PMID 41966200›Full record

ArticleInternational journal of health policy and management2025

Are Corporate Political Actors Aware of the Health Risks Associated With Their Products? Comment on "Corporate Political Activity: Taxonomies and Model of Corporate Influence on Public Policy".

Emanuel Orozco

Abstract readComment
In one paragraph

Article in International journal of health policy and management, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Emanuel OrozcoHealth Systems Research Centre, National Institute of Public Health, Morelos, Mexico.ORCID 0000-0002-6550-7385

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The analytical model proposal by Ulucanlar et al for the analysis of corporate political activity (CPA) establishes that corporate actors are aware of the high incidence of non-communicable diseases (NCDs) associated with their products and protect themselves against the consequences. This model helps to identify the strategies used by various corporate entities to influence public policies and protect their interests. The CPA analytical model applies a critical approach to commercial determinants of health that allows us to understand how corporate actors take advantage of their systems-based management of power. Due to its inherent complexity, this analysis presents several unanswered questions requiring along with theoretical and empirical challenges. The situation described in this commentary points to the importance of monitoring the CPA at a global and local level, identifying opportunities that favor the regulation of political influence, to reduce the influence of the commercial determinants of health on the NCDs.

Indexed as

CommerceHealth PolicyNoncommunicable DiseasesPoliticsPublic PolicyHumansCorporate Political ActivityHealth PolicyNon-communicable Diseases

Identifiers

PMID41966200
PMCPMC12573126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.